| North Country Home Health & Hospice Agency | |
| 536 Cottage Street, Littleton, New Hampshire 3561 | |
| (603) 444-5317 | |
| Name | North Country Home Health & Hospice Agency |
|---|---|
| Location | 536 Cottage Street, Littleton, New Hampshire |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 307009 |
| Ownership Type | Voluntary Non-profit - Other |
| Service Area Zip Codes | 3251, 3262, 3285, 3293, 3561, 3570, 3574, 3575, 3576, 3579, 3580, 3581, 3582, 3583, 3584, 3585, 3586, 3588, 3590, 3592, 3593, 3595, 3597, 3598, 3740, 3765, 3771, 3774, 3779, 3780, 3785 |
| NPI Number | 1114176716 |
| Organization Name | NORTH COUNTRY HOME HEALTH & HOSPICE AGENCY, INC. |
| Doing Business As | NORTH COUNTRY HOME HEALTH AGENCY, INC. |
| Address | 536 Cottage St, Littleton, NH 03561 |
| Phone Number | 603-444-5317 |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
| NPI Number | 1275536575 |
| Organization Name | NORTH COUNTRY HOME HEALTH & HOSPICE AGENCY, INC. |
| Doing Business As | NORTH COUNTRY HOME HEALTH AGENCY, INC. |
| Address | 536 Cottage St, Littleton, NH 03561 |
| Phone Number | 603-444-5317 |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
| Quality Rating: |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 97.1 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.3 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.6 | 99.6 |
| How often the home health team checked patients for depression | 98.4 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 89.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.2 | 96.4 |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 80.2 | 79.6 |
| How often patients got better at getting in and out of bed | 78.4 | 81.1 |
| How often patients got better at bathing | 79.8 | 82.3 |
| How often patients’ breathing improved | 87.3 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 91.3 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 74.7 | 75 |
| How often home health patients had to be admitted to the hospital | 13.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 17 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 97.4 | 94 |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
The patient survey data of North Country Home Health & Hospice Agency is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 76 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 83 | 78 |
News Archive
A "contingency management" approach—offering incentives for negative drug tests—can help promote drug abstinence among pregnant women with heroin or cocaine addiction, reports a study in the September Addictive Disorders & Their Treatment. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Absorption Systems, a leader in preclinical contract testing of drugs, biologics, and medical devices, announces that it has been subcontracted by the German pharmaceutical company Merck KGaA to work on a new pediatric formulation of praziquantel.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.
› Verified 3 days ago
North Country Home Health & Hospice Agency Location: 536 Cottage Street, Littleton, New Hampshire 3561 Ratings: Phone: (603) 444-5317 |